GAP program improves patients' quality of care.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D019090:Case Management; D019091:Critical Pathways; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D009732:Nursing Care; D010353:Patient Education as Topic; D017410:Practice Guidelines as Topic; D011787:Quality of Health Care; D016540:Smoking Cessation; D012955:Societies, Medical; D014481:United States
D000319:Adrenergic beta-Antagonists; D001241:Aspirin